This document discusses an interactive discussion forum on ICH Q7 and Q11 guidelines for good manufacturing practices. The discussion focused on whether a drug product can ensure safety if manufactured from a non-compliant active pharmaceutical ingredient. Participants also considered whether good manufacturing practices are required for pharmaceutical ingredients, processes, and products.